Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 19Breast Neoplasms 18Leukemia, Myeloid, Acute 9Ovarian Neoplasms 6Lymphoma 6Hematologic Neoplasms 6Glioblastoma 6Colorectal Neoplasms 6Prostatic Neoplasms 5Pancreatic Neoplasms 5Neoplasm Metastasis 5Multiple Myeloma 5Lung Neoplasms 5Stomach Neoplasms 4Leukemia 4Fatigue 4Vulvar Neoplasms 3Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Myelodysplastic Syndromes 3Motor Activity 3Depression 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Anxiety Disorders 3Vaginal Neoplasms 2Sarcoma 2Rectal Neoplasms 2Peritoneal Neoplasms 2Pain 2

Interventions

Gemcitabine 83Cisplatin 53Oxaliplatin 36lenvatinib 25Capecitabine 23durvalumab 22Fluorouracil 20Leucovorin 15tislelizumab 11pembrolizumab 11apatinib 10Radiotherapy 10Albumin-Bound Paclitaxel 10Radiofrequency Ablation 9Magnetic Resonance Spectroscopy 9Irinotecan 9Floxuridine 9Liver Transplantation 8Drug Therapy 8Cholangiopancreatography, Endoscopic Retrograde 8130-nm albumin-bound paclitaxel 8Taxes 7S 1 (combination) 7Platinum 7Photochemotherapy 7Panitumumab 7Biopsy 71,2-diaminocyclohexaneplatinum II citrate 7tremelimumab 6pemigatinib 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Cholangiocarcinoma × Palliative Care × Clear all
NCT06369480 2024-04-17

Prognostic Factors for Survival in Patients With Cholangiocarcinoma

Rigshospitalet, Denmark

Unknown
2,000 enrolled
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡